SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers
16 references·8 citing·28 second hop
Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers (2011)Psilocybin dose-dependently causes delaye…Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects (2011)Psilocybin occasioned mystica…Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies (2010)Acute, subacute and long-term…Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later (2008)Mystical-type experiences occ…Human hallucinogen research: guidelines for safety (2008)Human hallucinogen research: …Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (2006)Psilocybin can occasion mysti…Using Psilocybin to Investigate the Relationship between Attention, Working Memory, and the Serotonin 1A and 2A Receptors (2005)Using Psilocybin to Investiga…Hallucinogens (2004)HallucinogensAcute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose?effect study (2004)Acute psychological and physi…Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex (2003)Transcriptome Fingerprints Di…The pharmacology of psilocybin (2002)The pharmacology of psilocybinThe Psychology of Religion: An Empirical Approach (1998)The Psychology of Religion: A…Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action (1998)Psilocybin induces schizophre…Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis (1997)Positron Emission Tomography …Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man (1997)Determination of psilocin and…Dose-Response Study of N,N-Dimethyltryptamine in Humans (1994)Dose-Response Study of N,N-Di…The Psychology of Religion: An Empirical Approach (1986)The Psychology of Religion: A…Acute Adverse Effects of Therapeutic Doses of Psilocybin (2024)Acute Adverse Effects of Ther…Assessing the risk–benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research (2022)Assessing the risk–benefit pr…A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses (2020)A review of emerging therapeu…Psychedelic microdosing benefits and challenges: an empirical codebook (2019)Psychedelic microdosing benef…Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes (2014)Interaction of psychoactive t…Hallucinogen persisting perception disorder and the serotonergic system: A comprehensive review including new MDMA-related clinical cases (2014)Hallucinogen persisting perce…Fungal Hallucinogens Psilocin, Ibotenic Acid, and Muscimol (2013)Fungal Hallucinogens Psilocin…High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens (2012)High doses of dextromethorpha…Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer (2010)Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI) (2016)Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors (2017)Predicting Responses to Psychedelics: A Prospective Study (2018)DSM‐IV‐TR: Diagnostic and Statistical Manual of Mental Disorders (2013)The varieties of religious experience: A study in human nature. (1902)The PANAS-X: Manual for the Positive and Negative Affect Schedule - Expanded Form (1994)Psychological Assessment Resources (1995)The neurobiology of psychedelic drugs: implications for the treatment of mood disorders (2010)Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin (2015)"Mysticism and Philosophy" (1960)Psychedelics (2016)Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial (2016)Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder (2020)Mysticism and Philosophy (2024)Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior (2007)Psilocybin with psychological support for treatment-resistant depression: six-month follow-up (2017)Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness (2011)Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction (2014)Psychedelics and the essential importance of context (2018)The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act (2018)Emotions and brain function are altered up to one month after a single high dose of psilocybin (2020)Authoritarianism, Religious Fundamentalism, Quest, and Prejudice (1992)The Emerging Meanings of Religiousness and Spirituality: Problems and Prospects (1999)Psychedelics Promote Structural and Functional Neural Plasticity (2018)REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics (2019)The Psychology of Religion (2002)Religion as a Meaning‐Making Framework in Coping with Life Stress (2005)
this work references cited by second hop

References

  • 2006Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance1,682 cited
  • 1998The Psychology of Religion: An Empirical Approach1,339 cited
  • 2004Hallucinogens1,208 cited
  • 2008Human hallucinogen research: guidelines for safety1,201 cited
  • 1998Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action1,015 cited
  • 1986The Psychology of Religion: An Empirical Approach943 cited
  • 2011Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects932 cited
  • 2008Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later901 cited
  • 2010Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies531 cited
  • 2002The pharmacology of psilocybin463 cited
  • 1994Dose-Response Study of N,N-Dimethyltryptamine in Humans454 cited
  • 2004Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose?effect study451 cited
  • 1997Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis444 cited
  • 2003Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

296 cited
  • 1997Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man234 cited
  • 2005Using Psilocybin to Investigate the Relationship between Attention, Working Memory, and the Serotonin 1A and 2A Receptors231 cited
  • Cited by

    • 2019Psychedelic microdosing benefits and challenges: an empirical codebook124 cited
    • 2014Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes100 cited
    • 2024Acute Adverse Effects of Therapeutic Doses of Psilocybin98 cited
    • 2020A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses95 cited
    • 2012High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens90 cited
    • 2022Assessing the risk–benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research88 cited
    • 2014Hallucinogen persisting perception disorder and the serotonergic system: A comprehensive review including new MDMA-related clinical cases75 cited
    • 2013Fungal Hallucinogens Psilocin, Ibotenic Acid, and Muscimol75 cited